INNSBRUCK, Austria, Oct. 21, 2025 /PRNewswire/ -- Independent evaluations highlight trusted cybersecurity solutions, with registration now open for the CARO…
October 20, 2025 02:30 ET | Source: IO Biotech Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression…
CHARLOTTE, N.C., Oct. 15, 2025 /PRNewswire/ -- Bank of America reported its third quarter 2025 financial results today. The news…
WhatLatest Euro NCAP results published online and via social media.WhenWednesday 15 October - 11:00 a.m. CEST.WhereGo to Euro NCAP's Press Releases or…
SOUTHAMPTON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation (OTCID: ETCC) (“ETC” or the “Company”) today reported its…
Nearly all participants (11 of 12) experienced clinically meaningful hearing improvements, including three who achieved normal hearing; eight with longer…
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third…
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and…
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data 50 mg once-daily dose of obefazimod led…
September 2025 global sales of 268,238 units, up 7.3% Y/ySales in Korea climbed to 49,001 units, up 28.5% Y/yOutside of…